You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rydapt

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthcare Resource Utilization in Adults Diagnosed With Acute

Completed
  • Acute Myeloid Leukemia (AML)
  • Helsinki, Finland
    Novartis Investigative Site
Aug 3, 2022

Acute Myeloid Leukemia Trial in Germany (MODULE: conventional chemo (Cytarabine+Daunorubicin) in combination with

Active, not recruiting
  • Acute Myeloid Leukemia
  • MODULE: conventional chemotherapy (Cytarabine+Daunorubicin) in combination with midostaurin+GO
  • +4 more
  • München, Bayern, Germany
  • +10 more
Aug 31, 2021

Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

Recruiting
  • Acute Myeloid Leukemia
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
Jul 27, 2022

Acute Myeloid Leukemia Trial in United States (CPX-351, Venetoclax, Midostaurin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +9 more
Jan 3, 2023

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
Dec 29, 2021

Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +43 more
Nov 17, 2022

Acute Myeloid Leukemia Trial in Germany (midostaurin (PKC412))

Completed
  • Acute Myeloid Leukemia
  • midostaurin (PKC412)
  • Chemnitz, Germany
  • +9 more
Aug 5, 2020

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Jan 6, 2020

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

Acute Myeloid Leukemia (AML) Trial in France

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
    • Amiens, France
    • +28 more
    Jul 21, 2021

    Acute Myeloid Leukemia Trial in Gainesville (Midostaurin, Cytarabine)

    Withdrawn
    • Acute Myeloid Leukemia
    • Gainesville, Florida
      University of Florida
    Oct 18, 2018

    Acute Myeloid Leukemia With Gene Mutations, Adult Acute Myeloid Leukemia in Remission Trial (Midostaurin)

    Withdrawn
    • Acute Myeloid Leukemia With Gene Mutations
    • Adult Acute Myeloid Leukemia in Remission
    • (no location specified)
    May 1, 2018

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Anchorage, Alaska
    • +506 more
    Jan 28, 2023